Chronic Lymphocytic Leukemia Excellence Forum

Chronic Lymphocytic Leukemia

Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.

Videos

Managing Venetoclax Resistance in CLL

11/12/2019

Matthew S. Davids, MD, MMSc, discusses venetoclax resistance in CLL and how to manage patients resistant to the drug.

Matthew S. Davids, MD, MMSc,...

11/12/2019

Oncology

Videos

Treating CLL That Progress With BTK Inhibitor Therapy

11/12/2019

Richard Furman, MD, explains how best to control CLL patients who progress on BTK inhibitor therapy.

Richard Furman, MD, explains how...

11/12/2019

Oncology

Podcasts

Ibrutinib Demonstrates Long-Term Efficacy and Tolerability in Relapsed/Refractory CLL

09/14/2019

Paul Barr, MD, shares 6-year follow-up data from patients with CLL or SLL treated with ibrutinib on the RESONATE study.

Paul Barr, MD, shares 6-year...

09/14/2019

Oncology

Videos

Jacqueline C. Barrientos, MD, MS, Explains the Rationale for Using Combination Therapies in CLL

06/18/2019

Jacqueline C. Barrientos, MD, MS, explains why combining therapies is beneficial for the treatment of patients with CLL.

Jacqueline C. Barrientos, MD,...

06/18/2019

Oncology

Videos

The Importance of Sequencing Monotherapy in CLL

04/06/2019

Jacqueline C. Barrientos, MD, MS, explains the importance of sequencing monotherapy in chronic lymphocytic leukemia.

Jacqueline C. Barrientos, MD,...

04/06/2019

Oncology

Videos

Richard R. Furman, MD, Discusses Ibrutinib Versus FCR for Patients With CLL

04/06/2019

Richard R. Furman, MD, discusses ibrutinib compared with the standard chemoimmunotherapeutic regimen of intravenous fludarabine, cyclophosphamide, and rituximab, for patients with CLL.

Richard R. Furman, MD, discusses...

04/06/2019

Oncology

Podcasts

Practice-Changing Potential in CLL

02/19/2019

Anthony Mato, MD, MSCE, and colleagues share their choices of clinical trials and research in CLL that have the most potential to change the standard of care.

Anthony Mato, MD, MSCE, and...

02/19/2019

Oncology

Podcasts

CLL Novel Therapy Patterns, Dosing, and Sequencing: Results of the informCLL Real-World Registry

01/22/2019

Jeff Sharman, MD, discusses what the results of the informCLL real-world registry analysis indicate for CLL novel treatment patterns, dosing, and sequencing in practice.

Jeff Sharman, MD, discusses what...

01/22/2019

Oncology

Debates and Roundtables

Expert Roundtable: Lessons From ASH for Optimizing CLL Treatment

12/21/2018

Jeff Sharman, MD, Anthony Mato, MD, MSCE, and Chaitra Ujjani, MD, discussed the findings of an interim analysis from the prospective informCLL real-world registry and how to optimize CLL treatment in real-world practice.

Jeff Sharman, MD, Anthony Mato,...

12/21/2018

Oncology

Videos

Richard Furman, MD, Discusses Richter's Transformation and Emerging Therapies in CLL

11/08/2018

Dr Furman discusses disease progression with BTK inhibitor therapy, Richter's transformation, and emerging treatment options for CLL.

Dr Furman discusses disease...

11/08/2018

Oncology

Chronic Lymphocytic Leukemia Excellence Forum

Specialties

Events

Year Round Education

HMP Global Products